Pfizer names Albert Bourla group president
This article was originally published in Scrip
Executive Summary
Pfizer has named Albert Bourla group president of the vaccines, oncology and consumer healthcare business, effective 1 January 2014. He replaces Amy Schulman (www.scripintelligence.com, 17 December 2013), who was due to take up the position when the company began operating under its new three-armed commercial business structure in January 2014. Ms Schulman is stepping down from the company entirely but will remain for a transitional period. Meanwhile, Susan Silbermann has been named president and general manager, of Pfizer's global vaccines business – also effective 1 January 2014.